MercyOne and Corteva Agriscience announced that they have joined forces to fill the urgent need for the processing of COVID-19 samples with an initial focus on Iowa. MercyOne health care providers will collect the samples and deliver them to Corteva, where a small team of trained Corteva employees will process and assess the samples using the company’s sophisticated genetic screening capabilities.

“MercyOne is proud to be part of this innovation to meet the needs of our communities. Rapid test results are critical to re-open health care services and other essential businesses. We are grateful to collaborate with Corteva to leverage the strengths of both organizations and greatly appreciate the commitment of our colleagues for their ongoing dedication to meet the needs of our communities,” said Bob Ritz, President and Chief Executive Officer for MercyOne. “The testing provided through this program will initially be used within MercyOne care locations to provide confidence for our colleagues and patients.”

“I am so proud of the members of our team who conceived this initiative and are driving its execution. Our people have tremendous heart and are extraordinarily dedicated to making a difference in their communities; this is one of many great examples of that,” said Neal Gutterson, Senior Vice President and Chief Technology Officer at Corteva. “We are honored to collaborate with one of Iowa’s leading healthcare systems to help address this important need.”

Sample testing will begin today and is expected to continue for as long as the need remains critical. At this time there are no plans to collect samples at Corteva facilities.

This story was originally published by Corteva Agriscience on April 29, 2020 and can be found here.